You have no items in your shopping cart.
Description
Research Area
Images & Validation
−
| Application Notes |
|---|
Key Properties
−| Expression System | HEK293 |
|---|---|
| Target | TRAIL |
| Reactivity | Human |
| Tag | N-Fc |
| Expression Region | Val 114 - Gly 281 |
| Endotoxins | 1.0 EU per μg |
| Conjugation | Unconjugated |
| MW | 86.4 kDa |
| Purity | 90% |
Storage & Handling
−| Storage | -20°C |
|---|---|
| Form/Appearance | Powder |
| Buffer/Preservatives | PBS, pH 7.4 |
| Expiration Date | 6 months from date of receipt. |
| Disclaimer | For research use only |
Similar Products
−Recombinant Human TRAIL R4 Protein [orb2994136]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 43.4 KDa. Observed: 50-70 KDa, reducing conditions
500 μg, 1 mg, 10 μg, 50 μgRecombinant Mouse TRAIL R2 Protein [orb2994514]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 40.9 KDa. Observed: 50-75 KDa, reducing conditions
10 μg, 500 μg, 1 mg, 50 μgRecombinant Human TRAIL R2 Protein [orb2993994]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 42.2 KDa. Observed: 49 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgRecombinant Human TRAIL R3 Protein [orb2994005]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 48.7 KDa. Observed: 90 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mgRecombinant Human CD264/TNFRSF10D Protein, C-Fc [orb2966333]
ELISA, SDS-PAGE, WB
>95% as determined by SDS-PAGE.
45.42 kDa
1 mg, 100 μg, 50 μg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
